drugset / Trial / NCT05049343
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
RandomizedCrossoverQuadruple-blindTreatment
Summary
The primary purpose of this study is to determine functional target engagement of SAGE-904 using electrophysiological paradigms before and after ketamine administration.
Timeline
- Start
- 2021-09-21
- Primary completion
- 2021-11-20
- Completion
- 2021-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAGE-904 | Unknown | — | Oral |
| Background | Ketamine | Small molecule | — | Intravenous |
Indications
No indication recorded.